SCHEDULE: Bigger Capital, District 2 Disclose Neuraxis Stake
Beneficial Ownership Disclosure
Bigger Capital Fund L.P. and District 2 Capital Fund L.P., along with Michael Bigger, have disclosed their beneficial ownership in Neuraxis, Inc., totaling 8.60% of common stock.
Summary
- Bigger Capital Fund L.P. and its general partner, Bigger Capital Fund GP, LLC, beneficially own 763,975 shares of Neuraxis, Inc. common stock, representing 7.17% of the class.
- District 2 Capital Fund LP, along with its investment manager District 2 Capital LP, general partner District 2 GP LLC, and managing member District 2 Holdings LLC, beneficially own 151,714 shares, representing 1.42% of the class.
- Michael Bigger, as the managing member of both Bigger Capital Fund GP, LLC and District 2 Holdings LLC, is deemed to beneficially own an aggregate of 915,689 shares, representing 8.60% of the outstanding common stock.
- The percentages are based on 10,652,812 shares of common stock outstanding as of November 7, 2025, as reported in Neuraxis's Form 10-Q filed on November 10, 2025.
- The securities were not acquired or held for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of beneficial ownership, providing no direct positive or negative operational or financial information about the company.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional and individual ownership stakes, which can influence market perception and potential future corporate actions.
Key Dates
| Date | Description |
|---|---|
| 2025-09-30 | Date of event requiring the filing of this statement. |
| 2025-11-07 | Date as of which 10,652,812 shares of Common Stock were outstanding, per Issuer's Form 10-Q. |
| 2025-11-10 | Date Issuer's Form 10-Q was filed with the SEC. |
| 2025-11-11 | Date as of which beneficial ownership amounts and percentages are calculated. |
| 2025-11-12 | Signature date of the Schedule 13G filing. |
Keywords
Neuraxis, common stock, beneficial ownership, Schedule 13G, institutional investor, Bigger Capital, District 2 Capital, Michael Bigger, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.